Annual ROE
1.20%
-114.62%-98.96%
December 31, 2023
Summary
- As of February 22, 2025, CTMX annual return on equity is 1.20%, with the most recent change of -114.62% (-98.96%) on December 31, 2023.
- During the last 3 years, CTMX annual ROE has risen by +300.33% (+100.40%).
- CTMX annual ROE is now -100.00% below its all-time high of 25.24 thousand%, reached on December 31, 2021.
Performance
CTMX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-41.34%
-13.90%-50.66%
September 30, 2024
Summary
- As of February 22, 2025, CTMX quarterly return on equity is -41.34%, with the most recent change of -13.90% (-50.66%) on September 30, 2024.
- Over the past year, CTMX quarterly ROE has dropped by -54.53% (-413.42%).
- CTMX quarterly ROE is now -113.93% below its all-time high of 296.81%, reached on March 31, 2023.
Performance
CTMX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTMX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -99.0% | -413.4% |
| 3 y3 years | +100.4% | -413.4% |
| 5 y5 years | +101.4% | -413.4% |
CTMX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -113.9% | +95.1% |
| 5 y | 5-year | -100.0% | +100.4% | -113.9% | +95.1% |
| alltime | all time | -100.0% | +100.4% | -113.9% | +98.5% |
CytomX Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -41.34%(+50.7%) |
| Jun 2024 | - | -27.44%(-10.6%) |
| Mar 2024 | - | -30.70%(-3754.8%) |
| Dec 2023 | 1.20%(-99.0%) | 0.84%(-93.6%) |
| Sep 2023 | - | 13.19%(-82.1%) |
| Jun 2023 | - | 73.80%(-75.1%) |
| Mar 2023 | - | 296.81%(-135.4%) |
| Dec 2022 | 115.82%(-99.5%) | -839.30%(+189.0%) |
| Sep 2022 | - | -290.40%(+46.3%) |
| Jun 2022 | - | -198.50%(+37.0%) |
| Mar 2022 | - | -144.94%(-4.8%) |
| Dec 2021 | 25.24 K%(-8539.1%) | -152.29%(+25.6%) |
| Sep 2021 | - | -121.25%(-5.1%) |
| Jun 2021 | - | -127.82%(-13.0%) |
| Mar 2021 | - | -146.99%(-0.2%) |
| Dec 2020 | -299.13%(+104.9%) | -147.32%(+8.4%) |
| Sep 2020 | - | -135.90%(+5.9%) |
| Jun 2020 | - | -128.28%(+2.9%) |
| Mar 2020 | - | -124.69%(-8.3%) |
| Dec 2019 | -145.96% | -136.04%(+63.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -83.25%(-6.6%) |
| Jun 2019 | - | -89.16%(+7.5%) |
| Mar 2019 | - | -82.92%(-11.9%) |
| Dec 2018 | -84.28%(+45.1%) | -94.17%(+32.4%) |
| Sep 2018 | - | -71.12%(-4.7%) |
| Jun 2018 | - | -74.63%(-13.7%) |
| Mar 2018 | - | -86.47%(+28.4%) |
| Dec 2017 | -58.09%(+0.9%) | -67.37%(-20.8%) |
| Sep 2017 | - | -85.08%(+8.1%) |
| Jun 2017 | - | -78.67%(+40.2%) |
| Mar 2017 | - | -56.11%(-3.2%) |
| Dec 2016 | -57.59%(-61.3%) | -57.99%(-33.5%) |
| Sep 2016 | - | -87.14%(-3.2%) |
| Jun 2016 | - | -90.01%(-53.1%) |
| Mar 2016 | - | -191.82%(-93.1%) |
| Dec 2015 | -148.86%(-485.7%) | -2784.26%(-4016.0%) |
| Sep 2015 | - | 71.10%(-74.0%) |
| Jun 2015 | - | 273.04%(+1370.3%) |
| Mar 2015 | - | 18.57%(+74.2%) |
| Dec 2014 | 38.59%(+12.8%) | 10.66% |
| Dec 2013 | 34.20% | - |
FAQ
- What is CytomX Therapeutics annual return on equity?
- What is the all time high annual ROE for CytomX Therapeutics?
- What is CytomX Therapeutics annual ROE year-on-year change?
- What is CytomX Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly ROE year-on-year change?
What is CytomX Therapeutics annual return on equity?
The current annual ROE of CTMX is 1.20%
What is the all time high annual ROE for CytomX Therapeutics?
CytomX Therapeutics all-time high annual return on equity is 25.24 K%
What is CytomX Therapeutics annual ROE year-on-year change?
Over the past year, CTMX annual return on equity has changed by -114.62% (-98.96%)
What is CytomX Therapeutics quarterly return on equity?
The current quarterly ROE of CTMX is -41.34%
What is the all time high quarterly ROE for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly return on equity is 296.81%
What is CytomX Therapeutics quarterly ROE year-on-year change?
Over the past year, CTMX quarterly return on equity has changed by -54.53% (-413.42%)